MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$35,352,000
(26.78%↑ Y/Y)
Net loss before
income taxes
-$35,232,000
(27.02%↑ Y/Y)
Income tax expense
$120,000
Investment and other income
(expense), net
$2,623,000
(198.76%↑ Y/Y)
Loss from operations
-$37,855,000
(17.03%↑ Y/Y)
Total operating
expenses
$37,855,000
(-17.03%↓ Y/Y)
Research and development
$28,716,000
(5.39%↑ Y/Y)
General and
administrative
$9,139,000
(-13.62%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Zentalis Pharmaceuticals, Inc. (ZNTL)
Zentalis Pharmaceuticals, Inc. (ZNTL)